FeesSafety
Pluang+
Home/Explore/US Market Price/Stocks/CNI
icon
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Canadian National Railway Co. (CNI) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

CNI trades at $124.06, down 1.92% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $131.75. The company reported Q3 2026 EPS of $1.54, beating expectations, and maintains solid profitability with a 26.42% net income margin. Recent news highlights operational expansions, including a new grain facility in Illinois and an 8-year safety agreement with Amtrak.
The outlook is supported by steady cash flow and dividend payments, but risks include rising debt levels and economic sensitivity. Analyst sentiment is mixed with 33% buy ratings, suggesting cautious optimism amid competitive pressures and macroeconomic uncertainty.
Read full analysis

Key Stats

  • Market Cap
    $74.95B
  • Volume
    988,584
  • Sector
    Industrials
  • 52W High
    $130.58
  • 52W Low
    $90.91
  • Typical Hold Time
    105 Days
  • Enterprise Value
    $91.00B
  • Div Yield
    2.11%
  • Trading Activity
    -
$124.06
52W Low: $90.91
24 Nov 2025
52W High: $130.58
23 Jul 2026

Track Canadian National Railway Co. (CNI) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Canadian National Railway Co. has traded between a low of $90.91 and a high of $130.58, highlighting its annual price range. Buy and sell Canadian National Railway Co. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Canadian National Railway Co.

Canadian National's railway spans Canada from coast to coast and extends through Chicago to the Gulf of Mexico. In 2019, CN delivered almost 6 million carloads over its 19,600 miles of track. CN generated roughly CAD 14 billion in total revenue by hauling intermodal containers (25% of consolidated revenue), petroleum and chemicals (21%), grain and fertilizers (16%), forest products (12%), metals and mining (11%), automotive shipments (6%), and coal (4%). Other items constitute the remaining revenue.

Most Recent News

Content is generated by Aura AI

CRISPR Therapeutics reports positive Phase 1 results for zugo-cel in treating refractory autoimmune diseases.

CRISPR Therapeutics announced encouraging Phase 1 trial results for zugo-cel, their gene-edited CAR-T cell therapy targeting refractory autoimmune diseases like systemic sclerosis, lupus, and idiopathic inflammatory myopathy. Among 21 patients treate...

Market News
3 hours ago
Crispr Therapeutics
Bullish
news icon
CRISPR Therapeutics reports positive Phase 1 results for zugo-cel in treating refractory autoimmune diseases.

Velinotamig shows strong safety and efficacy in treating refractory systemic lupus erythematosus, with notable kidney improvements.

Cullinan Therapeutics announced promising Phase 1b/2a trial results for velinotamig, a BCMAxCD3 T cell engager, in patients with refractory moderate-to-severe systemic lupus erythematosus (SLE). Among nine evaluable patients, eight showed significant...

Market News
3 hours ago
Cullinan Therapeutics, Inc.
Bullish
news icon
Velinotamig shows strong safety and efficacy in treating refractory systemic lupus erythematosus, with notable kidney improvements.

New Phase 1/2 data show Cabaletta's rese-cel therapy offers durable, immunomodulator-free benefits in autoimmune diseases.

Cabaletta Bio announced Phase 1/2 clinical data for rese-cel, a CAR T cell therapy targeting autoimmune diseases, showing durable benefits without immunomodulators across dermatomyositis, lupus nephritis, and systemic sclerosis patients. All dermatom...

Market News
3 hours ago
Cabaletta Bio, Inc.
Bullish
news icon
New Phase 1/2 data show Cabaletta's rese-cel therapy offers durable, immunomodulator-free benefits in autoimmune diseases.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $74.95B
  • Volume
    988,584
  • Sector
    Industrials
  • 52W High
    $130.58
  • 52W Low
    $90.91
  • Typical Hold Time
    105 Days
  • Enterprise Value
    $91.00B
  • Div Yield
    2.11%
  • Trading Activity
    -
$124.06
52W Low: $90.91
24 Nov 2025
52W High: $130.58
23 Jul 2026

Track Canadian National Railway Co. (CNI) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Canadian National Railway Co. has traded between a low of $90.91 and a high of $130.58, highlighting its annual price range. Buy and sell Canadian National Railway Co. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!